云南高校图书馆联盟文献共享服务平台- BIVALIRUDIN

BIVALIRUDIN: 作品数：20被引量：56H指数：4; 导出分析报告; 相关领域：医药卫生更多>>; 相关作者：张亚臣相银唐勇更多>>; 相关机构：上海交通大学医学院附属新华医院青岛科技大学南京工业大学更多>>; 相关期刊：《Chinese Medical Journal》《World Journal of Cardiology》《Cardiovascular Innovations and Applications》《现代化工》更多>>; 相关基金：国家自然科学基金中国博士后科学基金更多>>

Bivalirudin for anticoagulation in elderly acute coronary syndrome:Effects on myocardial microcirculation and adverse events: 《World Journal of Clinical Cases》2025年第13期47-51,共5页Chun-Yao Cheng Wen-Rui Hao Tzu-Hurng Cheng; The management of acute coronary syndrome(ACS)in older patients remains challenging because standard anticoagulants often fail to yield optimal outcomes.Bivalirudin,a direct inhibitor of thrombin,serves as an alternat...; 关键词：BIVALIRUDIN Acute coronary syndrome Myocardial microcirculation Elderly patients ANTICOAGULATION

Effect of bivalirudin on myocardial microcirculation and adverse events after interventional therapy in older patients with acute coronary syndrome被引量：1: 《World Journal of Clinical Cases》2024年第22期4890-4896,共7页Ya-Kun Du Li-Jun Cui Hong-Bo Gao; BACKGROUND Bivalirudin,a direct thrombin inhibitor,is used in anticoagulation therapies as a substitute for heparin,especially during cardiovascular procedures such as percutaneous coronary intervention.AIM To explore...; 关键词：BIVALIRUDIN HEPARIN Acute coronary syndrome Corrected thrombolysis in myocardial infarction flow frame count Thrombolysis in myocardial infarction myocardial perfusion classification

基于连续流动化学的Bivalirudin绿色合成方法的研究: 《现代化工》2023年第11期140-144,149,共6页王振炜刘豪黄鼎旻苏贤斌; 省部共建生态化工协同创新中心人才基金资助(1203042904001419)。; 提出了一种新型绿色多肽合成方法,并成功将该方法应用于水蛭素的二十肽类似物Bivalirudin的合成。以苄氧羰基(Cbz)为氨基保护基,利用钯炭装填柱快速脱去Cbz保护,偶联反应及其后处理在微通道反应器内完成,实现了偶联-后处理-脱保护全体...; 关键词：连续流动化学微通道反应器比伐芦定多肽合成

Rationale and Design of a Randomized Controlled Trial of Bivalirudin with a Prolonged High-Dose Infusion Versus Heparin Monotherapy During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction:The BRIGHT-4 Trial被引量：1: 《Cardiology Discovery》2022年第4期226-230,共5页Zhenyang Liang Yi Li Gregg W.Stone Yaling Han; supported by the Chinese Society of Cardiology’s Foundation.; Intravenous anticoagulant therapy is critical to prevent ischemic events without increasing the risk of bleeding in patients with ST-segment elevation myocardial infarction(STEMI)undergoing primary percutaneous corona...; 关键词：HEPARIN BIVALIRUDIN ST-segment elevation myocardial infarction Primary percutaneous coronary intervention

Efficacy and safety of bivalirudin without post-procedure infusion in patients with coronary heart disease during elective percutaneous coronary intervention:a real-world study被引量：4: 《Chinese Medical Journal》2022年第1期116-118,共3页Ping Wang Xin Zhao Qimin Yuan Xiaoxue Yu Lin Yang Xiaozeng Wang; To the Editor:Antithrombotic therapy is essential to prevent adverse ischemic events during and after percutaneous coronary intervention(PCI).Anticoagulation during PCI is most commonly achieved with heparin or bivali...; 关键词：patients CORONARY INFUSION

Bivalirudin in Primary PCI: Can Its Glory Being Restored?被引量：1: 《Cardiology Discovery》2021年第3期179-194,共16页Yang Li Yi Li Gregg W.Stone Yaling Han; supported by the Key Research and Development Program of Liaoning Province(2020JH 2/10300167);Project of Science and Technology Plan of Shenyang(19-112-4-051);Cardiacare Sponsored Optimizing Antithrombotic Research Fund(BJUHFCSOARF201901-06).; Intravenous anticoagulant therapy is critical to prevent ischemic recurrences and complications without increasing the risk of bleeding in patients with ST-segment elevation myocardial infarction (STEMI) undergoing pr...; 关键词：BIVALIRUDIN HEPARIN ST-segment elevation myocardial infarction Primary percutaneous coronary intervention

Effects of Bivalirudin and Unfractionated Heparin on Liver and Renal Function in Chinese Patients with Coronary Artery Disease Undergoing Coronary Angiography with/without Percutaneous Coronary Intervention被引量：3: 《Journal of Clinical and Translational Hepatology》2021年第4期477-483,共7页Qiaowei Jia Jia Hu Wenfeng Ji Liansheng Wang Enzhi Jia; This study received support from the National Natural Science Foundations of China(No.81970302).; Background and Aims:Unfractionated heparin(UFH)and bivalirudin are widely used as anticoagulants in cardiovascular medicine,including for thrombosis prevention during coronary angiography(CAG)and percutaneous coronary...; 关键词：BIVALIRUDIN Unfractionated heparin Coronary artery disease Coro-nary angiography Percutaneous coronary intervention Liver function

Anticoagulation with direct thrombin inhibitors during extracorporeal membrane oxygenation被引量：13: 《World Journal of Critical Care Medicine》2019年第6期87-98,共12页Barry Burstein Patrick M Wieruszewski Yan-Jun Zhao Nathan Smischney; Use of extracorporeal membrane oxygenation to support patients with critical cardiorespiratory illness is increasing.Systemic anticoagulation is an essential element in the care of extracorporeal membrane oxygenation ...; 关键词：EXTRACORPOREAL membrane OXYGENATION ANTICOAGULANTS Antithrombins BIVALIRUDIN ARGATROBAN Heparin

Effects of bivalirudin on acute myocardial infarction in patients undergoing emergency percutaneous coronary intervention被引量：3: 《South China Journal of Cardiology》2018年第4期237-243,共7页SUN Xue-yu ZHANG Yu-ying HAN Zeng-lei; supported by Qingdao Municipal Health Commission Planning Project(No.2015-WJZD066); Background It.s an effective treatment to implement percutaneous coronary intervention in acute myocardial infarction patients,which rapidly achieve coronary reperfusion. However,many patients with no-reflow,leading t...; 关键词：acute myocardial infarction ANGIOPLASTY NO-REFLOW BIVALIRUDIN

Use of Bivalirudin for Anticoagulation in Interventional Cardiovascular Procedures: 《Cardiovascular Innovations and Applications》2018年第B07期163-174,共12页Zhen Ge Jaya Chandrasekhar Roxana Mehran; Anticoagulation is imperative to reduce the incidence of thrombotic complications in patients undergoing percutaneous interventional cardiovascular procedures;however,this is at the expense of increased risk of bleedi...; 关键词：BIVALIRUDIN ANTICOAGULATION INTERVENTIONAL CARDIOVASCULAR PROCEDURES

BIVALIRUDIN